These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 19368117)

  • 1. Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products.
    Hupfeld J; Efferth T
    In Vivo; 2009; 23(1):1-6. PubMed ID: 19368117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral drug resistance testing.
    Sen S; Tripathy SP; Paranjape RS
    J Postgrad Med; 2006; 52(3):187-93. PubMed ID: 16855319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 drug resistance among untreated patients in India: Current status.
    Pachamuthu B; Shanmugam S; Nagalingeswaran K; Solomon SS; Solomon S; Solomon S
    J Postgrad Med; 2006; 52(3):183-6. PubMed ID: 16855318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multiple benefits associated with HIV drug-resistance mutation M184V.
    Bean P
    Am Clin Lab; 2002 Mar; 21(2):16-8. PubMed ID: 11993249
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug failure during HIV-1 treatment. New perspectives in monitoring drug resistance.
    Re MC; Bon I; Monari P; Gorini R; Schiavone P; Gibellini D; La Placa M
    New Microbiol; 2003 Oct; 26(4):405-13. PubMed ID: 14596353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity, drug resistance, and the epidemic of subtype C HIV-1 in Africa.
    Katzenstein D
    J Infect Dis; 2006 Sep; 194 Suppl 1():S45-50. PubMed ID: 16921472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral drug resistance and HIV/AIDS in the developing world.
    Vella S
    J HIV Ther; 2002 Aug; 7(3):53-5. PubMed ID: 12442164
    [No Abstract]   [Full Text] [Related]  

  • 8. Plant substances as anti-HIV agents selected according to their putative mechanism of action.
    Cos P; Maes L; Vanden Berghe D; Hermans N; Pieters L; Vlietinck A
    J Nat Prod; 2004 Feb; 67(2):284-93. PubMed ID: 14987070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and clinical research of HIV-1 resistance in three AIDS patients who had experienced multiple regimens.
    Lu JF; Li J; Li HP; Liu SY; Zhuang DM; Liu YJ; Bao ZY; Li L; Wu H; Li JY
    Chin Med J (Engl); 2009 Mar; 122(6):752-4. PubMed ID: 19323948
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits and limitations of testing for resistance to HIV drugs.
    Richman DD
    J Antimicrob Chemother; 2004 Apr; 53(4):555-7. PubMed ID: 15014064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe.
    van de Vijver DA; Derdelinckx I; Boucher CA
    J Infect Dis; 2009 May; 199(9):1310-7. PubMed ID: 19301982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of HIV-1 resistant polymorphisms among HIV infected patients in Georgia.
    Karchava M; Nelson KE; Gochitashvili N; Dvali N; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):28-33. PubMed ID: 19124913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentials of phenolic molecules of natural origin and their derivatives as anti-HIV agents.
    Hassan Khan MT; Ather A
    Biotechnol Annu Rev; 2007; 13():223-64. PubMed ID: 17875479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine-resistant variants of HIV-1 in lung.
    Gates A; Coker R; Miller R; Mitchell D; Williamson J; Clarke J
    AIDS; 1997 Apr; 11(5):702-3. PubMed ID: 9108966
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggressive HIV-1?
    Berkhout B; de Ronde A; van der Hoek L
    Retrovirology; 2005 Feb; 2():13. PubMed ID: 15737238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.
    Assoumou L; Brun-Vézinet F; Cozzi-Lepri A; Kuritzkes D; Phillips A; Zolopa A; Degruttola V; Miller V; Costagliola D;
    J Infect Dis; 2008 Aug; 198(4):470-80. PubMed ID: 18598191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there any hope for AIDS?
    Wainberg MA
    Clin Invest Med; 2004 Feb; 27(1):51-8. PubMed ID: 15061586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies for structure-guided design of AIDS antivirals.
    Blundell TL
    Prog Biophys Mol Biol; 2005 Jun; 88(2):191-2. PubMed ID: 15572154
    [No Abstract]   [Full Text] [Related]  

  • 20. Current developments in anti-HIV/AIDS gene therapy.
    Tsygankov AY
    Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.